Meeting
2018 ASCO Annual Meeting
Incidence of ototoxicity in head and neck cancer (HNSCC) patients (pts) receiving concomitant chemo-radiation (CRT) with weekly or triweekly cisplatin (Cis).
Authors
Jishu Das
Ohio State University Comprehensive Cancer Center, Columbus, OH
Jishu Das , Amy Custer , Dukagjin Blakaj , Matthew O. Old , Songzhu Zhao , Aashish D Bhatt , Stephan Y Kang , Amit Agrawal , Enver Ozer , Jessica Wobb , Robert Rupert Jr., Darrion L Mitchell , Guy Brock , Claire F. Verschraegen , James William Rocco , Marcelo R Bonomi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6046)
DOI
10.1200/JCO.2018.36.15_suppl.6046
Abstract #
6046
Poster Bd #
34
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
The RADIO trial: Randomized assessment of cisplatin dosing interval for ototoxicity with curative concurrent chemo-radiation for locally advanced head and neck squamous cell carcinoma.
First Author: Sara Kuruvilla
Poster
2020 ASCO Virtual Scientific Program
Cisplatin every three weeks versus weekly cisplatin or carboplatin with definitive radiotherapy for squamous cell carcinoma of the head and neck is associated with improved overall survival in a representative national population.
First Author: Michael Gerard McCusker
Poster
2018 ASCO Annual Meeting
Cisplatin-induced ototoxicity in head and neck squamous cell carcinoma (HNSCC) patients treated with chemoradiation: The role of WFS1 and ABCC2 heritable variants.
First Author: Mary Mahler
Poster
2017 ASCO Annual Meeting
Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial.
First Author: Jean Bourhis